Blood Group Typing Market to reach $5.3 billion by 2035

Blood group typing market was valued at $3.1 billion in 2025 and is projected to reach $5.3 billion by 2035, growing at a CAGR of 5.6% during the forecast period (2026-2035). The increasing demand for safe and reliable blood transfusion continues to act as a primary growth driver for the blood group typing market. According to the World Health Organization (2025), approximately 118.54 million blood donations are collected annually across 169 countries, highlighting the scale of transfusion-related activities within healthcare systems. Despite this volume, supply gaps persist across several regions, necessitating continuous expansion of blood collection and testing infrastructure. In parallel, national healthcare programs are strengthening blood safety frameworks and expanding transfusion services to meet rising clinical needs. For instance, WHO data indicates that India’s annual blood collection increased from 12.6 million units in 2023 to 14.6 million units in 2024, with further growth anticipated in 2025. This steady increase in blood collection volumes directly translates into higher demand for blood grouping, antibody screening, and cross-matching procedures. The need for standardized and accurate diagnostic solutions across blood banks and hospitals is therefore becoming increasingly critical.

Browse the full report description of “Blood Group Typing Market Size, Share & Trends Analysis Report by Product Type (Instruments, Consumables & Reagents), by Test Type (ABO Blood Typing, Rh Typing, Antibody Screening, Cross-Matching Tests), by Application (Blood Transfusion, Organ Transplantation, Prenatal Testing, Forensic Testing, Research & Academic Use), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/blood-group-typing-market

The demand is further reinforced by the growing emphasis on transfusion safety and regulatory compliance across healthcare systems. WHO highlights that nearly 120 million units of blood are utilized annually, yet many countries continue to face challenges in ensuring timely and safe access. To address these gaps, governments are implementing structured haemovigilance systems and mandating stringent testing protocols across the entire transfusion chain. In addition, disparities in donation rates across income groups, with significantly higher donation rates in developed healthcare systems, are encouraging investments in advanced diagnostic infrastructure. These policy-driven initiatives are increasing the adoption of automated and high-precision blood typing technologies. As healthcare systems continue to scale transfusion services and improve quality standards, the requirement for reliable blood typing solutions remains structurally embedded, supporting sustained market expansion.

Innovation Leaders Transforming the Blood Group Typing Market

The key players in the Blood Group Typing market include Bio-Rad Laboratories, Inc., Grifols, S.A., Danaher Corporation, QuidelOrtho Corporation, Thermo Fisher Scientific Inc, among others. These companies are advancing innovation in blood group typing solutions through the development of high-precision immunohematology systems, enhanced reagent formulations, and automated diagnostic platforms, enabling accurate and efficient blood compatibility testing across clinical and laboratory settings while supporting the increasing demand for safe transfusion practices and improved patient outcomes.

• In June 2025, Devyser announced the global launch of Devyser Genomic Blood Typing, a next-generation sequencing (NGS)-based solution that redefines molecular blood group research. Developed exclusively, this all-in-one assay enables comprehensive genetic blood typing, covering red blood cell (RBC), human platelet antigen (HPA), and human neutrophil antigen (HNA) systems in a single, streamlined test.

• In May 2024, New York Blood Center Enterprises (NYBCe) announced today that it is collaborating with Thermo Fisher Scientific to co-develop the Applied Biosystems Axiom BloodGenomiX Array and BloodGenomiX Reporter Software that provides a high-throughput solution for more precise blood matching to enable safer transfusions. The array is a first-of-its-kind solution for more precise blood genotyping. The new array detects common, extended, and rare blood groups, tissue (HLA) and platelet (HPA) types in a single, high-throughput assay, supporting future advancements in donor and patient blood group matching for blood transfusion.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Test Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Bio-Rad Laboratories, Inc., Grifols, S.A., Danaher Corporation, QuidelOrtho Corporation, Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Blood Group Typing Market Report Segment

By Product Type

• Instruments
• Consumables & Reagents

By Test Type

• ABO Blood Typing
• Rh Typing
• Antibody Screening
• Cross-Matching Tests

By Application

• Blood Transfusion
• Organ Transplantation
• Prenatal Testing
• Forensic Testing
• Research & Academic Use

Global Blood Group Typing Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/blood-group-typing-market